| Molecular characterization of carbapenem-resistant serotype K1 hypervirulent Klebsiella pneumoniae ST11 harbouring blaNDM-1 and blaOXA-48 carbapenemases in Iran H Solgi, F Shahcheraghi, N Bolourchi, A Ahmadi Microbial Pathogenesis 149, 104507, 2020 | 34 | 2020 |
| Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii N Bolourchi, F Shahcheraghi, AS Shirazi, A Janani, F Bahrami, ... Microbial pathogenesis 131, 9-14, 2019 | 25 | 2019 |
| Comparative resistome and virulome analysis of clinical NDM-1–producing carbapenem-resistant Enterobacter cloacae complex N Bolourchi, CG Giske, S Nematzadeh, A Mirzaie, SS Abhari, H Solgi, ... Journal of Global Antimicrobial Resistance 28, 254-263, 2022 | 20 | 2022 |
| Effects of cefazolin-containing niosome nanoparticles against methicillin-resistant Staphylococcus aureus biofilm formed on chronic wounds M Zafari, M Adibi, M Chiani, N Bolourchi, SM Barzi, MSS Nosrati, Z Bahari, ... Biomedical Materials 16 (3), 035001, 2021 | 19 | 2021 |
| Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals N Bolourchi, F Shahcheraghi, CG Giske, S Nematzadeh, ... Annals of Clinical Microbiology and Antimicrobials 20, 1-11, 2021 | 15 | 2021 |
| Identification of novel putative immunogenic targets and construction of a multi-epitope vaccine against multidrug-resistant Corynebacterium jeikeium using reverse vaccinology … S Shahbazi, S Sabzi, NN Goodarzi, S Fereshteh, N Bolourchi, B Mirzaie, ... Microbial Pathogenesis 164, 105425, 2022 | 11 | 2022 |
| Comparative in silico characterization of Klebsiella pneumoniae hypervirulent plasmids and their antimicrobial resistance genes N Bolourchi, A Naz, M Sohrabi, F Badmasti Annals of Clinical Microbiology and Antimicrobials 21 (1), 23, 2022 | 10 | 2022 |
| Investigation of novel putative immunogenic targets against Staphylococcus aureus using a reverse vaccinology strategy NN Goodarzi, N Bolourchi, S Fereshteh, AS Shirazi, MR Pourmand, ... Infection, Genetics and Evolution 96, 105149, 2021 | 10 | 2021 |
| Genome-Wide Subtraction Analysis and Reverse Vaccinology to Detect Novel Drug Targets and Potential Vaccine Candidates Against Ehrlichia chaffeensis S Sabzi, S Shahbazi, N Noori Goodarzi, F Haririzadeh Jouriani, M Habibi, ... Applied Biochemistry and Biotechnology 195 (1), 107-124, 2023 | 9 | 2023 |
| Comprehensive pan-genomic, resistome and virulome analysis of clinical OXA-48 producing carbapenem-resistant Serratia marcescens strains N Bolourchi, NN Goodarzi, CG Giske, S Nematzadeh, FH Jouriani, ... Gene 822, 146355, 2022 | 8 | 2022 |
| The combination of CipA and PBP-7/8 proteins contribute to the survival of C57BL/6 mice from sepsis of Acinetobacter baumannii F Badmasti, M Habibi, F Firoozeh, S Fereshteh, N Bolourchi, NN Goodarzi Microbial Pathogenesis 158, 105063, 2021 | 8 | 2021 |
| Reverse vaccinology approach to identify novel and immunogenic targets against Porphyromonas gingivalis: An in silico study O Nasiri, M Hajihassani, N Noori Goodarzi, S Fereshteh, N Bolourchi, ... Plos one 17 (8), e0273770, 2022 | 7 | 2022 |
| Immunization with recombinant DcaP-like protein and AbOmpA revealed protections against sepsis infection of multi-drug resistant Acinetobacter baumannii ST2Pas in a C57BL/6 … FB Sepideh Fereshteh a, Soheila Ajdary b, Amin Sepehr a, Negin Bolourchi a ... Microbial Pathogenesis 174, 2023 | 5 | 2023 |
| Clonal relatedness of Acinetobacter baumannii isolated from the Middle East: a systematic review N Bolourchi, O Azizi, AMA Tabrizi, S Esmaeili, S Fereshteh, F Badmasti Reviews and Research in Medical Microbiology 33 (1), e48-e56, 2022 | 4 | 2022 |
| A bioinformatics approach to introduce novel multi-epitope vaccines against Acinetobacter baumannii retrieved from immunogenic extracellular loops of outer membrane proteins S Fereshteh, NN Goodarzi, N Bolourchi, MK Asforooshani, A Salimi, ... Informatics in Medicine Unlocked, 2022 | 3 | 2022 |
| Subtractive genomic approach toward introduction of novel immunogenic targets against Clostridioides difficile: Thinking out of the box NN Goodarzi, S Fereshteh, O Azizi, H Rahimi, N Bolourchi, F Badmasti Microbial Pathogenesis 162, 105372, 2022 | 3 | 2022 |
| Introduction of novel putative immunogenic targets against Proteus mirabilis using a reverse vaccinology approach NN Goodarzi, N Bolourchi, S Fereshteh, F Badmasti Infection, Genetics and Evolution 95, 105045, 2021 | 3 | 2021 |
| Subtractive genomic analysis for computational identification of putative immunogenic targets against clinical Enterobacter cloacae complex N Bolourchi, S Fereshteh, N Noori Goodarzi, F Badmasti Plos one 17 (10), e0275749, 2022 | 2 | 2022 |
| Evolutionary genomics of recent clinical Bordetella pertussis isolates from Iran: wide circulation of multiple ptxP3 lineages and report of the first ptxP3 filamentous … A Safarchi, S Saedi, S Octavia, M Sedaghatpour, N Bolourchi, CY Tay, ... Infection, Genetics and Evolution 93, 104970, 2021 | 2 | 2021 |
| Genome analysis of an OXA-48-producing carbapenem-and colistin-resistant Klebsiella pneumoniae sequence type 11 clone isolated from an inpatient N Bolourchi, F Shahcheraghi, CG Giske, S Nematzadeh, H Solgi, ... Gene Reports 25, 101394, 2021 | 1 | 2021 |
Farzad BadmastiAssociate Professor of Bacteriology at Pasteur Institute of Iran在 pasteur.ac.ir 的电子邮件经过验证
